Introduction:
The pharmaceutical industry in the United States is a significant contributor to the global market, with a focus on generic drugs and raw materials. In recent years, the demand for generic drugs has been on the rise due to their cost-effectiveness and accessibility. According to a recent report, the generic drug market in the USA is expected to reach $239.8 billion by 2025, with a CAGR of 10.2% from 2020 to 2025.
Top 10 Generic Drug Raw Material & Excipient Suppliers in USA:
1. Lonza Group AG
– Market share: 12%
– Lonza Group AG is a leading supplier of raw materials and excipients for generic drugs in the USA, with a strong presence in the market due to its high-quality products and reliable supply chain.
2. Evonik Industries AG
– Market share: 9%
– Evonik Industries AG is another key player in the generic drug raw material and excipient market, offering a wide range of products to meet the diverse needs of pharmaceutical companies in the USA.
3. Kerry Group
– Market share: 8%
– Kerry Group is known for its innovative solutions in the pharmaceutical industry, providing high-quality raw materials and excipients that meet the stringent requirements of the FDA.
4. BASF SE
– Market share: 7%
– BASF SE is a globally recognized supplier of raw materials and excipients for generic drugs, with a strong presence in the USA market due to its extensive product portfolio and reliable supply chain.
5. Merck KGaA
– Market share: 6%
– Merck KGaA is a leading supplier of raw materials and excipients for generic drugs in the USA, known for its high-quality products and commitment to sustainability in the pharmaceutical industry.
6. Roquette Frères
– Market share: 5%
– Roquette Frères is a key player in the generic drug raw material and excipient market, offering a wide range of plant-based ingredients that meet the growing demand for natural products in the pharmaceutical industry.
7. Ashland Global Holdings Inc.
– Market share: 4%
– Ashland Global Holdings Inc. is a trusted supplier of raw materials and excipients for generic drugs in the USA, known for its innovative solutions and commitment to quality in the pharmaceutical industry.
8. Croda International Plc
– Market share: 3%
– Croda International Plc is a leading supplier of raw materials and excipients for generic drugs in the USA, offering a comprehensive range of products that meet the evolving needs of pharmaceutical companies.
9. Innophos Holdings Inc.
– Market share: 2%
– Innophos Holdings Inc. is a key player in the generic drug raw material and excipient market, known for its high-quality products and customer-centric approach to business in the pharmaceutical industry.
10. Sumitomo Chemical Co., Ltd.
– Market share: 1%
– Sumitomo Chemical Co., Ltd. is a global supplier of raw materials and excipients for generic drugs, with a growing presence in the USA market due to its strong R&D capabilities and commitment to innovation in the pharmaceutical industry.
Insights:
The generic drug market in the USA is poised for significant growth in the coming years, driven by factors such as increasing demand for cost-effective medications and a growing aging population. Key players in the raw material and excipient supply chain will need to focus on innovation and sustainability to meet the evolving needs of pharmaceutical companies. According to industry analysts, the generic drug raw material and excipient market in the USA is expected to grow at a CAGR of 8% from 2021 to 2026, reaching a market size of $15.6 billion by the end of the forecast period. As such, companies that can adapt to changing market dynamics and provide high-quality products will be well-positioned for success in the coming years.
Related Analysis: View Previous Industry Report
